Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nussbaum, NC"'
Autor:
Parrinello, CM, Seidl-Rathkopf, KN, Bennette, CS, Bourla, AB, Nussbaum, NC, Carson, KR, Abernethy, AP
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S14-S15
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S14-S14
Autor:
Torres AZ; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA., Nussbaum NC; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA.; New York University School of Medicine, New York, NY, USA., Parrinello CM; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA.; Pine Mountain Consulting, LLC., Redding, CT, USA., Bourla AB; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA., Bowser BE; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA., Wagner S; Bristol-Myers Squibb, Princeton, NJ, USA., Tabano DC; Bristol-Myers Squibb, Princeton, NJ, USA., George D; Duke University, Durham, NC, USA., Miksad RA; Flatiron Health, Inc., 233 Spring Street, Fifth Floor, New York, NY, 10025, USA. ramiksad@flatiron.com.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Jun; Vol. 39 (6), pp. 2831-2849. Date of Electronic Publication: 2022 Apr 17.
Autor:
Zhang Q; Flatiron Health Inc, New York, New York, USA., Gossai A; Flatiron Health Inc, New York, New York, USA., Monroe S; Flatiron Health Inc, New York, New York, USA., Nussbaum NC; Flatiron Health Inc, New York, New York, USA., Parrinello CM; Flatiron Health Inc, New York, New York, USA.
Publikováno v:
Health services research [Health Serv Res] 2021 Dec; Vol. 56 (6), pp. 1281-1287. Date of Electronic Publication: 2021 May 17.
Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer.
Autor:
Riaz F; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States; Cancer Outcomes, Public Policy and Effectiveness Research Center, 367 Cedar Street, New Haven, CT 06510, United States. Electronic address: Fauzia.Riaz@yale.edu., Presley CJ; The Ohio State University Comprehensive Cancer Center and The James Cancer Hospital/Solove Research Institute, 460 W 10th Ave, Columbus, OH 43210, United States; Cancer Outcomes, Public Policy and Effectiveness Research Center, 367 Cedar Street, New Haven, CT 06510, United States., Chiang AC; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States., Longtine JA; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States., Soulos PR; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States; Cancer Outcomes, Public Policy and Effectiveness Research Center, 367 Cedar Street, New Haven, CT 06510, United States., Adelson KB; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States; Cancer Outcomes, Public Policy and Effectiveness Research Center, 367 Cedar Street, New Haven, CT 06510, United States., Herbst RS; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States., Nussbaum NC; Flatiron Health, 233 Spring St, New York, NY 10013, United States; New York University School of Medicine, 550 1st Avenue, New York, NY 10016, United States., Sorg RA; Flatiron Health, 233 Spring St, New York, NY 10013, United States., Abernethy AP; Flatiron Health, 233 Spring St, New York, NY 10013, United States., Agarwala V; Flatiron Health, 233 Spring St, New York, NY 10013, United States; Stanford University School of Medicine, 291 Campus Drive, Stanford, CA 94305, United States., Gross CP; Yale Cancer Center, 333 Cedar Street, New Haven, CT 06510, United States; Cancer Outcomes, Public Policy and Effectiveness Research Center, 367 Cedar Street, New Haven, CT 06510, United States.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2019 Jul; Vol. 10 (4), pp. 669-672. Date of Electronic Publication: 2019 Feb 02.
Autor:
Liede A; Center for Observational Research, Amgen Inc., Thousand Oaks and South San Francisco, California, USA., Hernandez RK; Center for Observational Research, Amgen Inc., Thousand Oaks and South San Francisco, California, USA., Wade SW; Center for Observational Research, Amgen Inc., Thousand Oaks and South San Francisco, California, USA.; Wade Outcomes Research and Consulting, Salt Lake City, Utah, USA., Bo R; Center for Observational Research, Amgen Inc., Thousand Oaks and South San Francisco, California, USA., Nussbaum NC; Flatiron Health, New York, USA.; Department of Medicine, New York University School of Medicine, New York, USA., Ahern E; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.; Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Australia., Dougall WC; Immuno-oncology Discovery Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Sep 05; Vol. 7 (12), pp. e1480301. Date of Electronic Publication: 2018 Sep 05 (Print Publication: 2018).
Autor:
Presley CJ; The Ohio State University, Medical Oncology, Columbus., Tang D; Yale School of Public Health, New Haven, Connecticut., Soulos PR; Yale School of Medicine, New Haven, Connecticut., Chiang AC; Yale School of Medicine, New Haven, Connecticut., Longtine JA; Yale School of Medicine, New Haven, Connecticut., Adelson KB; Yale School of Medicine, New Haven, Connecticut., Herbst RS; Yale School of Medicine, New Haven, Connecticut., Zhu W; Yale School of Medicine, New Haven, Connecticut., Nussbaum NC; Flatiron Health, New York, New York.; New York University School of Medicine, New York., Sorg RA; Flatiron Health, New York, New York., Agarwala V; Flatiron Health, New York, New York.; Stanford University School of Medicine, Stanford, California., Abernethy AP; Flatiron Health, New York, New York., Gross CP; Yale School of Medicine, New Haven, Connecticut.
Publikováno v:
JAMA [JAMA] 2018 Aug 07; Vol. 320 (5), pp. 469-477.
Autor:
O'Connor JM; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut., Fessele KL; Flatiron Health Inc, New York, New York., Steiner J; Flatiron Health Inc, New York, New York., Seidl-Rathkopf K; Flatiron Health Inc, New York, New York., Carson KR; Flatiron Health Inc, New York, New York., Nussbaum NC; Flatiron Health Inc, New York, New York., Yin ES; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut., Adelson KB; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Presley CJ; The Ohio State University Comprehensive Cancer Center, Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus., Chiang AC; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Ross JS; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut., Abernethy AP; Flatiron Health Inc, New York, New York., Gross CP; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
JAMA oncology [JAMA Oncol] 2018 Aug 01; Vol. 4 (8), pp. e180798. Date of Electronic Publication: 2018 Aug 09.
Autor:
Khozin S; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Abernethy AP; Flatiron Health, New York, New York, USA amy@flatiron.com., Nussbaum NC; Flatiron Health, New York, New York, USA., Zhi J; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Curtis MD; Flatiron Health, New York, New York, USA., Tucker M; Flatiron Health, New York, New York, USA., Lee SE; Flatiron Health, New York, New York, USA., Light DE; Flatiron Health, New York, New York, USA., Gossai A; Flatiron Health, New York, New York, USA., Sorg RA; Flatiron Health, New York, New York, USA., Torres AZ; Flatiron Health, New York, New York, USA., Patel P; Flatiron Health, New York, New York, USA., Blumenthal GM; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The oncologist [Oncologist] 2018 Mar; Vol. 23 (3), pp. 328-336. Date of Electronic Publication: 2018 Jan 09.